168412-89-3

Basic information

• Product Name: 1-azido-6-(4-phenylbutoxy)hexane
• Synonyms: 1-azido-6-(4-phenylbutoxy)hexane
• CAS NO: 168412-89-3
• Molecular Weight: 275.394
• Mol File: 168412-89-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-azido-6-(4-phenylbutoxy)hexane(CAS DataBase Reference)
• NIST Chemistry Reference: 1-azido-6-(4-phenylbutoxy)hexane(168412-89-3)
• EPA Substance Registry System: 1-azido-6-(4-phenylbutoxy)hexane(168412-89-3)

Safety Data

• Hazardous Substances Data: 168412-89-3(Hazardous Substances Data)

Upstream product

• 94749-73-2 6-bromohexyl 4-phenylbutyl ether 
• 629-03-8 1 ,6-dibromohexane 
• 3360-41-6 4-phenyl-butan-1-ol 

Downstream Products

• 928118-30-3 [6-(4-phenylbutoxy)hexyl]carbamic acid ter-butyl ester 
• 160889-19-0 2-Benzyloxy-5-((R)-2-{benzyl-[6-(4-phenyl-butoxy)-hexyl]-amino}-1-hydroxy-ethyl)-benzoic acid methyl ester 
• 135271-47-5 (R)-(-)-salmeterol 
• 135271-47-5 (S)-Salmeterol 
• 97664-55-6 N-[6-(4-phenylbutoxy)hexyl]benzenemethanamine 
• 97664-58-9 D 2543 

Relevant articles and documents

Enantioselective synthesis of salmeterol via asymmetric borane reduction

Enantioselective syntheses of both enantiomers of salmeterol are accomplished using asymmetric borane reductions with chiral oxazaborolidines as catalysts.

BENZYLPHOSPHATE AND SUBSTITUTED BENZYLPHOSPHATE PRODRUGS FOR TRE TREATMENT OF PULMONARY INFLAMMATION

A prodrug of a corticosteroid, lidocaine or related local anesthetic composition for formulation for delivery by aerosolization to inhibit inflammation in asthmatic lungs is described. The prodrug is preferably formulated in a 5 ml solution of a quarter normal saline having pH between 5.0 and 7.0 for the treatment of respiratory tract inflammation by an aerosol having mass medium average diameter predominantly between 1 to 5 μ produced by nebulization or dry powder inhaler.